Otsuka Precision Health, a prescription digital therapeutics company, and Amalgam Rx, a holdings company in the pharmaceutical and nutraceutical market, have launched Elevmi, a digital application designed to help caregivers assist family members who…
Continue Reading
Otsuka Precision Health, a prescription digital therapeutics company, and Amalgam Rx, a holdings company in the pharmaceutical and nutraceutical market, have launched Elevmi, a digital application designed to help caregivers assist family members who…
Continue Reading
Last month, an app named Rejoyn became the first FDA-cleared prescription digital therapeutic for patients with major depressive disorder. The app, which changes users’ behavior through various lessons and exercises, was developed by Otsuka…
Continue Reading
